Brief: Gimv Sells Imcheck Therapeutics Stake To Ipsen For EUR 350 Mln
22/10/2025 06:34
Oct 22 (Reuters) - Gimv NV GIMV.BR: SALE OF ITS STAKE IN IMCHECK THERAPEUTICS TO IPSEN CLOSING PURCHASE PRICE OF 350 MILLION EURO AND POTENTIAL MILESTONE PAYMENTS TOTALING NEARLY 1 BILLION EURO TRANSACTION IS EXPECTED TO CLOSE BY END OF Q1 2026 WILL RECEIVE AN UPFRONT CASH PAYMENT THAT REPRESENTS A REALIZED MONEY MULTIPLE OF 2.6X ON OUR TOTAL INVESTMENT POSITIVE IMPACT OF APPROXIMATELY 0.4 EURO PER SHARE COMPARED TO UNAUDITED NAV COMMUNICATED IN THE TRADING UPDATE AT THE BEGINNING OF SEPT Source text: https://tinyurl.com/3setwcj4 Further company coverage: GIMV.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))